https://biospectrumindia.com/rssfeed/bio-interactions/webinars webinars https://biospectrumindia.com/news/35/20061/-qa-bio-expert-post-discovery-priorities-streamlining-your-molecules-route-to-ind.html https://biospectrumindia.com/news/35/20061/-qa-bio-expert-post-discovery-priorities-streamlining-your-molecules-route-to-ind.html Fri, 26 Nov 2021 00:00:00 +0530   Thermo Fisher Scientific           WEBINARInvitation to Thermo Fisher Scientific India webinar Contact Us   Join Thermo Fisher Scientific India webinar on December 2nd and 9th 2PM (IST) to learn latest trends on clinical trials and biologics development with Thermo Fisher Scientific’s offerings. Register Now for Day1(2Dec) Register Now for Day2(9Dec)  December 2nd at 2PM (IST) Day 1: Clinical trials – Uncovering the unseen boundaries Agenda Session 1: Patheon™ Fisher Clinical Services overview(by Subashri Shivkumar, Director and GM, Clinical Trials, Thermo Fisher Scientific) Session 2: Comparator sourcing overview capabilities(by Natalia Kozik, Program Manager, Comparator Sourcing, Thermo Fisher Scientific) Session 3: Importance of a one-stop-shop for clinical packaging and labeling in a GMP environment(by Robert Scarth, General Manager, Global Label Services, Thermo Fisher Scientific) Subashri Shivkumar,Director and GM, Clinical Trials, Thermo Fisher Scientific Natalia Kozik Program Manager, Comparator Sourcing, Thermo Fisher Scientific Robert Scarth General Manager, Global Label Services, Thermo Fisher Scientific Click the button to register Day 1 webinar Register Now (Day1)  December 9th at 2PM (IST) Day 2: Biologics development: Balancing speed and risk to clinic Agenda Session 1: Pharma Services – Introduction to integrated service offerings(by Ankita Barve, Business Development Executive, Pharma Services, Thermo Fisher Scientific) Session 2: Development of large molecule drug substances into effective therapies(by Palak Patel, Scientist, Cell Culture Development, Thermo Fisher Scientific) Session 3: How an integrated global network of technical, quality and customer engagement teams can support the drug development journey for biologics(by Vincenza Pironti, PhD, MBA, Global SME, Sterile Drug Products, Thermo Fisher Scientific) Ankita BarveBusiness Development Executive, Pharma Services, Thermo Fisher Scientific Palak Patel Scientist, Cell Culture Development, Thermo Fisher Scientific Vincenza PirontiPhD, MBA, Global SME,Sterile Drug Products,Thermo Fisher Scientific Click the button to register Day 2 webinar Register Now (Day2)     Patheon India Liaison Office / Ahmedabad Ankita Barve ankita.barve@thermofisher.com  (CDMO Service) Fisher Biopharma Services (India) Pvt Ltd /Ahmedabad Ajitpal Singh ajitpal.singh@thermofisher.com Jay M jay.m@thermofisher.com (Clinical Supply Chain Management Services)  Thermo Fisher Scientific, 4815 Emperor Blvd., Durham, NC 27703-8470, USA | +1 919-226-3200 thermofisher.com/patheon  |  pharmaservices@thermofisher.com  |  Privacy Information Center © 2021 Thermo Fisher Scientific Inc. All Rights Reserved. This email was sent to {{Lead.Email Address}}. If you no longer wish to receive these emails you may unsubscribe at any time. ]]> https://biospectrumindia.com/news/35/19535/ict-to-host-training-workshop-on-covid-19-from-oct-4-8-2021.html https://biospectrumindia.com/news/35/19535/ict-to-host-training-workshop-on-covid-19-from-oct-4-8-2021.html Fri, 10 Sep 2021 10:55:00 +0530 Institute of Chemical Technology (ICT), Mumbai and its flagship initiative Biosimilar Workshop: Digital Edition will be conducting a workshop focussed on COVID-19, in virtual mode from October 4-8, 2021, as a four-part webinar series organised over 5 days.The workshop will impart training and insight directly from experts and academicians of the biopharmaceutical, diagnostic and vaccine industries on crucial steps and details of the latest research and development taking place in the respective fields.The workshop commenced in 2017 as an annual endeavour to stimulate and encourage discussion as well as innovation of new technologies in various sectors of the biopharmaceutical industry.Keeping in mind the unprecedented changes brought to the world due to the SARS-CoV-2 pandemic, the 2021 Digital Edition of the Biosimilar Workshop aims to enlighten all participants on the recent research in diagnosis, therapeutic interventions and analytical characterisation of the SARS-CoV-2 virus.This year, the biosimilar workshop will have leaders from the biopharmaceutical field, who will provide a seasoned perspective on topics such as: structural analysis of the SARS-CoV-2 spike protein pre/post-fusion conformations and interactions with ACE2 or neutralising antibodies; Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation; Reading and writing the genome with precision; The journey of India's first indigenous SARS-CoV-2 vaccine (Covaxin), to name a few. ]]> https://biospectrumindia.com/news/35/19219/nha-invites-comments-on-consultation-paper-over-unified-health-interface.html https://biospectrumindia.com/news/35/19219/nha-invites-comments-on-consultation-paper-over-unified-health-interface.html Fri, 23 Jul 2021 17:55:00 +0530 The National Health Authority (NHA) released a consultation paper on the Unified Health Interface (UHI). UHI is intended to be an open, interoperable platform to connect all digital health solutions.   The consultation paper provides an overview of the proposed design, scope and role of UHI. In light of the upcoming national rollout of NDHM, comments from the public are invited to ensure that UHI is designed and developed in a collaborative and consultative manner.    Through the UHI, NDHM aims to transform the way digital health services are rendered in India. Currently, patients and healthcare providers need to be on the same application to avail and provide digital health services, respectively. It is envisioned that the open network created by UHI will serve as the digital infrastructure for patients and healthcare providers to engage in the discovery, booking, payment and fulfilment of a variety of digital health services across applications. The services include but are not limited to, teleconsultation and the discovery of pharmacies and hospitals. Over time, the services enabled by the platform will evolve with the market ecosystem. UHI is designed to be similar to the UPI (Unified Payments Interface) ecosystem which has emerged for digital payments.   Since the launch of the pilot of NDHM in August 2020 in six Union Territories, multiple rounds of consultations with different groups of stakeholders have been held for the various building blocks to discuss the design and adoption. NDHM will continue this engagement with stakeholders and ensure that development is inclusive, and that diverse viewpoint are incorporated from concerned stakeholders.   Giving his views on the consultation papers, Dr RS Sharma, CEO, National Health Authority, remarked, “The National Digital Health Mission (NDHM) is endeavouring to make digital public goods for the healthcare industry to make it more accessible, affordable and efficient. To facilitate this, we are taking a consultative approach to develop the National Digital Health Ecosystem. We have come up with the concept of Unified Health Interface (UHI), designed on similar lines as UPI (Unified Payment Interface), which has revolutionized digital payments and the financial sector. To enable inclusivity and widen the perspectives on the table, I urge all stakeholders to go through the shared consultation papers and provide us with their valuable feedback.”   NHA will also organise a public webinar on UHI to explain the consultation paper on August 4, 2021, from 3 pm onwards. ]]> https://biospectrumindia.com/news/35/19125/virtual-workshop-on-cgmps-in-indian-medical-devices-held.html https://biospectrumindia.com/news/35/19125/virtual-workshop-on-cgmps-in-indian-medical-devices-held.html Fri, 09 Jul 2021 16:15:00 +0530 The fourth of a series of six virtual workshops on current Good Manufacturing Practices to support the Indian pharmaceutical / Medical Devices industry’s vision of providing world-class quality medical products was inaugurated by Dr Renu Swarup, Secretary, Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India.    The initiative is the result of an active collaboration between the Union Ministry of Health & Family Welfare (MoHFW), Department of Biotechnology (DBT), Ministry of Science and Technology, the World Health Organization (WHO), JSS Academy of Higher Education & Research at Mysuru (JSS AHER), AMTZ and the Indian Pharmaceutical Alliance (IPA).   Dr Swarup said, “This initiative of providing the requirements of Global standards meets the critical need of enabling further up-gradation of in vitro diagnostics and medical devices sector for achieving global standards of quality. This will have a far-reaching positive impact. It reiterates our commitment to quality medical products.”    Welcoming the capacity-strengthening workshops, Dr VG Somani, Drug Controller General of India, said, “We are committed to the highest regulatory standards to ensure quality, safety and efficacy of medical products. This workshop conducted by a team from WHO PQ IVD Assessment team would support Indian medical devices units to upgrade their quality culture to global standards.”    “The virtual workshop for medical devices units is a key step in that direction, and we are delighted to partner in this path-breaking programme,” said Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance.    National and international experts, including from WHO (HQ, Regional Office for South-East Asia, Country Office for India) and leading industry voices came together to design a need-based workshop programme.    Dr Jitendra Sharma, Managing Director & CEO, Andhra Pradesh Med Tech Zone (AMTZ) said that the workshop would propel the Indian medical devices industries to higher global standards.   Shirish Belapure, Senior Technical Advisor, at Indian Pharmaceutical Alliance, said, “IPA Quality forum has one prime objective of upgrading the quality of Indian pharmaceuticals and medical devices industries and this workshop is supporting the realisation of the same.”   Dr Anup Anvikar, Director, National Institute of Biologicals (NIB), Veena Kohli, President, Association of Diagnostics Manufacturers of India (ADMI) and Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AIMED) also graced the occasion.   ]]> https://biospectrumindia.com/views/35/18689/watch-on-demand-parexel-webinar.html https://biospectrumindia.com/views/35/18689/watch-on-demand-parexel-webinar.html Thu, 20 May 2021 00:00:00 +0530   Watch Now        ]]> https://biospectrumindia.com/features/35/17523/watch-on-demand-sartorius-webinar.html https://biospectrumindia.com/features/35/17523/watch-on-demand-sartorius-webinar.html Tue, 03 Nov 2020 00:00:00 +0530   Watch Now      ]]> https://biospectrumindia.com/features/35/17489/watch-on-demand-promega-webinar.html https://biospectrumindia.com/features/35/17489/watch-on-demand-promega-webinar.html Wed, 28 Oct 2020 00:00:00 +0530 In this webinar, we will discuss Complete workflow for Sangerseuqencing Promega Spectrum Compact CE System for Sanger sequencing and fragment analysis instrument Overview of key applications on Spectrum Compact such microsatellite instability analysis, mixed sample analysis, forensic STR analysis, and cell line authentication.   Watch on Demand      For questions , please contact digital@mmactiv.com      ]]> https://biospectrumindia.com/reports-white-papers/35/16507/watch-on-demand-from-detection-to-vaccine-research-manufacturing.html https://biospectrumindia.com/reports-white-papers/35/16507/watch-on-demand-from-detection-to-vaccine-research-manufacturing.html Thu, 21 May 2020 00:00:00 +0530 Thermo Fisher Scientific is an industry-leading, worldwide, trusted partner with comprehensive, end-to-end solutions for pathogen detection, vaccine development and manufacturing. With the coronavirus (2019-nCov) outbreak, we are committed to helping clinicians, researchers and Bio-pharma industry for rapidly detecting as well as accelerating work on therapeutic vaccines. Find out more about our scientific expertise and the support capabilities in a learning and discussion webinar Watch On Demand : COVID19 Solutions by Thermo Fisher Scientific      ]]> https://biospectrumindia.com/news/35/16338/watch-on-demand-webinar-impurity-profiling-knowledge-accelerator.html https://biospectrumindia.com/news/35/16338/watch-on-demand-webinar-impurity-profiling-knowledge-accelerator.html Wed, 29 Apr 2020 01:05:00 +0530 Synopsis: The recent nitrosamine impurity crisis has firmly put the spotlight on genotoxic impurities (GTIs). Regulatory agencies, including US FDA and European Medicines Agency (EMA), have issued guidelines on allowable limits of genotoxic impurities in pharmaceutical products. These limits are to ensure product safety, not just for the ones frequently highlighted because of nitrosamines, but for all potentially contaminated drugs and processes in a company's portfolio of active pharmaceutical ingredients (APIs). In this knowledge accelerator , our presenter were focusing on below summarized topics  Dr. BM Rao (Head - EM QA, ASAT & CQC, Dr. Reddy's Laboratories Limited) had discussed about current challenges in quality control laboratories, best practices and next generation solutions in the pharmaceutical ecosystem   Dr. Anoop Kumar (Business Manager, SCIEX India) had discussed the rapid, sensitive and robust qualitative and quantitative analysis of genotoxic nitrosamines in Sartan products using SCIEX LC-MS/MS instrumentation to surpass current and future limits set by regulatory agencies   Watch on Demand -  Webinar    For any queries and more information on Sciex Products , please reach out to marketing.india@sciex.com ]]> https://biospectrumindia.com/reports-white-papers/35/14255/free-webinar-multiplex-fluorescence-immunohistochemistry.html https://biospectrumindia.com/reports-white-papers/35/14255/free-webinar-multiplex-fluorescence-immunohistochemistry.html Tue, 23 Jul 2019 00:00:00 +0530 However, the multiplexing capabilities of fluorescence IHC, using standard histology equipment, are subject to several technical challenges. This webinar will provide insight and examples of how the Ultivue InSituplex platform may be used to address several of the current challenges associated with multiplex fluorescence immunohistochemistry. It will focus on initial user experiences using the InSituPlex platform using automated IHC on the Leica Biosystems BOND RX and automated imaging with the Leica Biosystems Aperio Versa. Learning Objectives: Understanding technical challenges associated with tyramide-based multiplex fluorescence IHC. What tools are available today for multiplex? SPEAKER BIOGRAPHIES Traci DeGeer : Global Product and Innovation Manager-BOND RX Leica Biosystems Traci DeGeer is the Product Innovation Manager for the BOND RX platform, at Leica Biosystems. In this capacity she helps access new technologies for the Life Science research business, manages relationships with partners, works with legal partners to put agreements in place and liaises with Business Units to meet partner/customer needs as technologies are being developed. Traci holds a Bachelor of Science, in Biology, an HT, HTL, and QIHC for the anatomic pathology lab and recently graduated the HBx core program. Traci also holds a patent in small molecule detection for PDL-1 and has spoken at over one hundred state, regional and global symposia on various topics. Traci also sits on the ASCP Board of Certification (HT, HTL and QIHC Exam) and is the current Education Chair for the National Society of Histotechnology.   Alexander Klimowicz : Principal Scientist, Boehringer Ingelheim Pharmaceuticals Alex Klimowicz is a Principal Scientist in the Department of Immunology and Respiratory Discovery Research at Boehringer Ingelheim Pharmaceuticals, Inc. In this capacity he leads the Molecular Histopathology Group, implementing and applying cutting edge in situ techniques, whole slide imaging, and digital image analysis, to build target to disease linkage in human tissue specimens for projects and external collaborations across the Department. Alex holds a PhD in Molecular Biology, and has 10 years of experience in the fields of digital pathology and quantitative immunohistochemistry. Prior to moving to Boehringer Ingelheim, Alex was an Adjunct Research Assistant Professor in the Department of Oncology at the University of Calgary, where he led a core quantitative immunohistochemistry lab focused on cancer biomarker research. Click here to register and know more     ]]> https://biospectrumindia.com/reports-white-papers/35/13949/webinar-requirements-for-the-latest-elemental-impurities-.html https://biospectrumindia.com/reports-white-papers/35/13949/webinar-requirements-for-the-latest-elemental-impurities-.html Thu, 20 Jun 2019 09:00:00 +0530 West Pharma Webinar Wednesday, 5th December 2018 14:00 (Singapore) | 11:30 (India) | 16:00 (Australia) Kwang Kok Li Manager for TCS Generics Mkt & AP Join West expert Kwang Kok Li for a free webinar discussing the requirements for testing elemental impurities. Key Highlights:  Potential sources of elemental impurities  Current regulations and guidelines on the elemental impurities testing and specifications  Correlations to drug product quality and safety Speaker's Biography: Associated with West Pharmaceutical Services Singapore since 10 years, Kok Li has been involved in the technical support of customers in the Asia Pacific. To address technical issues, she works closely with customers and provides solutions to accelerate customer's time to market.   Click here to watch webinar on demand  ]]> https://biospectrumindia.com/reports-white-papers/35/13950/webinar-there-is-an-app-for-that-see-how-lims-mobile-applications-can-improve-your-laboratorys-workflow-whilst-aiding-in-your-regulatory-compliance.html https://biospectrumindia.com/reports-white-papers/35/13950/webinar-there-is-an-app-for-that-see-how-lims-mobile-applications-can-improve-your-laboratorys-workflow-whilst-aiding-in-your-regulatory-compliance.html Thu, 20 Jun 2019 09:00:00 +0530 Abbott Webinar Tuesday, 9th April 2019 HK time 1130 (Sydney time: 1430, India time: 0900, NZ time: 1630) Tiffany Gabriel Senior Business Consultant Abbott Informatics Topic: "There is an app for that! See how LIMS mobile applications can improve your laboratory's workflow whilst aiding in your regulatory compliance" Synopsis: The mobility features of modern LIMS solutions can aid in regulatory compliance and allow labs to operate whilst on the go. Looking at a typical analyst workflow, they do not always have access to a computer right at the time of needing one. Mobile applications greatly improve laboratory workflows as users have access to the information they need at all times. For example, mobile applications can allow lab managers to check reports, assign testing or authorise results directly from their handheld devices no matter their physical location to optimize action time. Benefits: Attend this webinar to learn more about: How LIMS mobile applications can aid in your compliance How mobile applications can improve your laboratory workflow How STARLIMS can enhance the value of your data How a LIMS can support your organization on saving time and money   Speaker's Biography: Tiffany is an experienced LIMS consultant and business analyst, responsible for implementing LIMS software solutions. She has over 15 years of experience implementing LIMS technology solutions across multiple platforms and client industries. After receiving her Bachelor of Science (Chemistry) at the University of Newcastle, Tiffany joined Alphapharm, a generics pharmaceutical manufacturer, as a Chemist and was responsible for implementing a LIMS into their laboratory. After six years administrating the system, she joined Abbott Informatics as a consultant where she has led the implementation of STARLIMS solutions across different sectors. Click to here watch webinar on demand  ]]> https://biospectrumindia.com/reports-white-papers/35/13951/webinar-a-solution-for-navigating-the-challenges-in-every-phase-of-the-pharma-life-cycle.html https://biospectrumindia.com/reports-white-papers/35/13951/webinar-a-solution-for-navigating-the-challenges-in-every-phase-of-the-pharma-life-cycle.html Thu, 20 Jun 2019 09:00:00 +0530 Starlims Webinar Date: 18 June India time: 0930, Hong Kong time: 1200, Sydney time: 1400 Tiffany Gabriel Senior Business Consultant Abbott Informatics Topic: A solution for navigating the challenges in every phase of the pharma life cycle Synopsis: How do you ensure smooth and efficient progression throughout your product's life cycle? From discovery to post marketing, each phase along the way comes with a unique set of data management challenges. In this webinar, we introduce you to a laboratory information management systems (LIMS) and demonstrate how this software can help you achieve regulatory compliance, quality data management throughout your product lifecycle. Automated data management software allows for an effective means to manage all aspects of pharmaceutical development, manufacturing, and testing in one convenient, easy-to-use software program. Benefits: How a LIMS can be a solution to your data management challenges How it handles our information; organization, tracking, scheduling, and monitoring functions Advanced analytics capabilities for critical business decision making Data security and regulatory compliance features Unique functional benefits of STARLIMS solutions within each phase of the pharmaceutical product life cycle Speaker's Biography: Tiffany is an experienced LIMS consultant and business analyst, responsible for implementing LIMS software solutions. She has over 15 years of experience implementing LIMS technology solutions across multiple platforms and client industries. After receiving her Bachelor of Science (Chemistry) at the University of Newcastle, Tiffany joined Alphapharm, a generics pharmaceutical manufacturer, as a Chemist and was responsible for implementing a LIMS into their laboratory. After six years administrating the system, she joined Abbott Informatics as a consultant where she has led the implementation of STARLIMS solutions across different sectors. Click here to watch webinar on demand ]]>